Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
No NICE guidance : NICE has not issued any technology appraisal or clinical guideline relating to retatrutide, as it is not yet a licensed product
Understanding the Connection Saxenda (liraglutide 3.0 mg) is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed by the MHRA for weight management in adults with obesity or overweight with weight-related comorbidities
If patients experience severe gastrointestinal symptoms or dehydration, stopping GLP-1 therapy temporarily is advisable
When weight drops quickly, your body sheds fat and muscle
In between-drug comparisons, tirzepatide at doses of 15 mg, 10 mg and 5 mg demonstrated greater efficacy than semaglutide at doses of 2.0 mg (MD = 4.60 kg [95% CI 7.94, 1.26]), 1.0 mg (MD = 3.53 kg [95% CI 4.80, 2.25]) and 0.5 mg (MD = 2.75 kg [95% CI 4.23, 1.28]), respectively (ESM Table 11)
US$ 20.43
US$ 26.54
US$ 21.95
US$ 28.05
